Joshua Mandel-Brehm
Independent DirectorMr. Joshua Mandel-Brehm, also known as Josh, serves as an Independent Director at ProMIS Neurosciences, Inc. September 2021 and served as its Director since September 1, 2021. He has also been a founder and board member for Vico Therapeutics B.V. since October 2019. He served as an Entrepreneur Partner at Polaris Partners since 2018. Previously, he served as an Entrepreneur in Residence at the firm since 2017 till 2018. He joined the firm in 2017. He serves as President, Chief Executive Officer and Director at CAMP4 Therapeutics Corporation since 2017 and served as its Treasurer, Secretary and as entrepreneur partner with Polaris Partners and as a member of board of directors since 2017. Mr. Mandel-Brehm serves as the Chief Executive Officer of Marauder Therapeutics. Prior to Polaris, he has held leadership roles in business development and operations. He served as a Senior Director in the business development and mergers & acquisitions group at Biogen. He led multiple strategic activities and corresponding transactions, which included expanding Biogen's non-malignant hematology franchise and leading seminal investments to enter the ophthalmology field. While at Biogen, he was at the center of gene therapy strategy and executed a series of external collaborations including Biogen's Partnership with the University of Pennsylvania. He spent time as the Head of strategy and operations for Biogen's rare disease group. Prior to his work at Biogen, he worked at Genzyme as part of the business development group for the rare disease business unit. Mr. Mandel-Brehm earned his BA in biology from Washington University in St. Louis, BA in Neurophysiology from 2001 to 2005 and holds an MBA in Finance and Corporate from the University for Michigan- Stephen M. Ross School of Business from 2007 to 2009.
Positions
- Company NameProMIS Neurosciences, Inc.Stock CodePMNPositionIndependent DirectorColleagues
- EWEugene W. WilliamsCo-Founder & Chairman
- NKNeil K. WarmaCEO, President, Compliance Officer & Director
- NRNeil R. CashmanCo-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
- JKJohanne KaplanChief Development Officer
- LDLarry Douglas AltstielChief Medical Officer
- WWWilliam W. WymanIndependent Director
- JMJoshua Mandel-BrehmIndependent Director
- Company NameCamp4 Therapeutics CorporationStock CodeCAMPPositionCEO, President & Director
